Table 2 Base Case - Influence of PDC rates on health care expenditures

(Intercept)

− 1089.26

1916.40

−0.57

0.5698

Age

55 < 65

611.05

687.99

0.89

0.3745

65 < 75

323.90

642.00

0.50

0.6139

≥ 75

− 1481.82

647.83

−2.29

0.0222*

Gender

Female

−147.47

309.84

−0.48

0.6341

BMI

underweight

1076.18

1814.31

0.59

0.5531

overweight

−287.73

365.01

−0.79

0.4306

obese

−407.75

395.78

−1.03

0.3029

BIMD 2010 (Q1 least deprived, Q5 most deprived)

Q2

− 600.25

427.80

−1.40

0.1606

Q3

− 935.95

459.42

− 2.04

0.0417*

Q4

− 535.59

454.13

−1.18

0.2383

Q5

− 812.27

430.76

−1.89

0.0594

Smoker

yes

157.39

447.42

0.35

0.7250

NYHA

1

2552.83

810.15

3.15

0.0016**

2

1548.90

482.24

3.21

0.0013**

3

2887.35

434.52

6.64

0.0000***

4

4533.88

457.35

9.91

0.0000***

DMP COPD

yes

1206.22

517.34

2.33

0.0197*

DMP asthma

yes

− 829.61

872.64

−0.95

0.3418

DMP diabetes type 1

yes

1946.15

2436.29

0.80

0.4244

DMP diabetes type 2

yes

519.76

288.19

1.80

0.0713

deceased

yes

11,012.39

925.20

11.90

0.0000***

HMG assignments per month

1.09

0.24

4.45

0.0000***

Year after AMI

− 5914.40

168.43

−35.11

0.0000***

days insured

34.48

4.72

7.31

0.0000***

Angina pectoris

2115.66

280.69

7.54

0.0000***

Peripheral vascular disease

4415.08

396.30

11.14

0.0000***

Dyslipidemia

480.99

365.24

1.32

0.1879

Congestive heart failure

2074.91

352.90

5.88

0.0000***

Hypertension

1939.37

574.43

3.38

0.0007***

Dialysis

23,554.62

991.15

23.77

0.0000***

edf

Ref.df

F

p-value

s (PDC mean ACE inhibitors) male

1.26

1.26

0.09

0.7234

s (PDC mean ACE inhibitors) female

1.00

1.00

1.45

0.2292

s (PDC mean β-blockers) male

1.00

1.00

3.01

0.0827

s (PDC mean β-blockers) female

1.29

1.29

0.12

0.8398

s (PDC mean statins) male

1.78

1.78

1.98

0.0851

s (PDC mean statins) female

1.00

1.00

1.43

0.2310

s (PDC mean anti-platelet agents) male

2.99

2.99

21.63

0.0000***

s (PDC mean anti-platelet agents) female

3.08

3.08

4.34

0.0055**

s (PDC standard deviation ACE inhibitors) male

1.90

1.90

0.97

0.4112

s (PDC standard deviation ACE inhibitors) female

2.51

2.51

5.11

0.0038**

s (PDC standard deviation β-blockers) male

3.25

3.25

12.01

0.0000***

s (PDC standard deviation β-blockers) female

1.00

1.00

2.77

0.0960

s (PDC standard deviation statins) male

1.00

1.00

0.26

0.6070

s (PDC standard deviation statins) female

3.35

3.35

2.97

0.0368*

s (PDC standard deviation anti-platelet agents) male

3.99

3.99

4.23

0.0023**

s (PDC standard deviation anti-platelet agents) female

2.69

2.69

4.04

0.0116*